NCT00726661View on ClinicalTrials.gov

An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer (VIRGO)

CompletedOBSERVATIONAL
Enrollment

1,287

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Breast Cancer
Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY

NCT00726661 - An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer (VIRGO) | Biotech Hunter | Biotech Hunter